In the latest trading session, 32.85 million Cognition Therapeutics Inc (NASDAQ:CGTX) shares changed hands as the company’s beta touched 1.01. With the company’s most recent per share price at $0.58 changing hands around $0.06 or 12.33% at last look, the market valuation stands at $24.11M. CGTX’s current price is a discount, trading about -408.62% off its 52-week high of $2.95. The share price had its 52-week low at $0.34, which suggests the last value was 41.38% up since then.
Analysts gave the Cognition Therapeutics Inc (CGTX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CGTX as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Cognition Therapeutics Inc’s EPS for the current quarter is expected to be -0.15.
Cognition Therapeutics Inc (NASDAQ:CGTX) trade information
Instantly CGTX is in green as seen in intraday trades today. With action -7.89%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -17.25%, with the 5-day performance at -7.89% in the red. However, in the 30-day time frame, Cognition Therapeutics Inc (NASDAQ:CGTX) is -18.27% down.
Cognition Therapeutics Inc (CGTX) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -21.09%. The 2025 estimates are for Cognition Therapeutics Inc earnings to increase by 4.46%, but the outlook for the next 5-year period is at 9.38% per year.
Cognition Therapeutics Inc (NASDAQ:CGTX)’s Major holders
AWM INVESTMENT COMPANY, INC. holds the second largest percentage of outstanding shares, with 1.6224% or 0.65 million shares worth $1.08 million as of 2024-06-30.
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 1.01 shares estimated at $0.58 million under it, the former controlled 2.43% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.48% of the shares, roughly 200.58 shares worth around $0.12 million.
